PREVALENCE OF TUBERCULOSIS AND RIFAMPICIN RESISTANT Mycobacterium tuberculosis AMONG PATIENTS RECEIVING TREATMENT IN ERCC MEDICAL CENTER ALUSHI, NASARAWA STATE, NIGERIA.

International Journal of Science Letters Pub Date : 2023-03-25 DOI:10.38058/ijsl.1233908

Emmanuel Oboh

{"title":"PREVALENCE OF TUBERCULOSIS AND RIFAMPICIN RESISTANT Mycobacterium tuberculosis AMONG PATIENTS RECEIVING TREATMENT IN ERCC MEDICAL CENTER ALUSHI, NASARAWA STATE, NIGERIA.","authors":"Emmanuel Oboh","doi":"10.38058/ijsl.1233908","DOIUrl":null,"url":null,"abstract":"The purpose of this study was to estimate the prevalence of tuberculosis among patients undergoing treatment at the ERCC medical centre in Alushi from January 2017 to July 2021. A total of 3029 TB presumptive patients were included in the current investigation. The overall TB prevalence was 43.57%. There were 993 (64.90%) males, 10.1% of whom were rifampicin resistant, and 537 (35.09%) females, 34.8% of whom were rifampicin resistant. The highest prevalence is recorded in all age groups, was seen in the age bracket 21-30 with a total of 350 (26.51%) and 327 (24.77%) in the age range 31-40. Findings revealed that having a history of TB medication and being female were both associated with the development of rifampicin-resistant Tuberculosis and patients aged 21 to 40 were more likely than others to be infected with tuberculosis and develop rifampicin-resistant tuberculosis. Because of the high prevalence, immediate action is essential to encourage early identification and the completion of DR-TB medication in order to prevent the disease from spreading in the community, as well as continuous community health education about tuberculosis and the risk of drug resistance","PeriodicalId":287513,"journal":{"name":"International Journal of Science Letters","volume":"13 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Science Letters","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.38058/ijsl.1233908","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

The purpose of this study was to estimate the prevalence of tuberculosis among patients undergoing treatment at the ERCC medical centre in Alushi from January 2017 to July 2021. A total of 3029 TB presumptive patients were included in the current investigation. The overall TB prevalence was 43.57%. There were 993 (64.90%) males, 10.1% of whom were rifampicin resistant, and 537 (35.09%) females, 34.8% of whom were rifampicin resistant. The highest prevalence is recorded in all age groups, was seen in the age bracket 21-30 with a total of 350 (26.51%) and 327 (24.77%) in the age range 31-40. Findings revealed that having a history of TB medication and being female were both associated with the development of rifampicin-resistant Tuberculosis and patients aged 21 to 40 were more likely than others to be infected with tuberculosis and develop rifampicin-resistant tuberculosis. Because of the high prevalence, immediate action is essential to encourage early identification and the completion of DR-TB medication in order to prevent the disease from spreading in the community, as well as continuous community health education about tuberculosis and the risk of drug resistance

查看原文本刊更多论文

尼日利亚纳萨拉瓦州阿鲁希ERCC医疗中心接受治疗的患者中结核病和耐利福平结核分枝杆菌的患病率。

本研究的目的是估计2017年1月至2021年7月在Alushi ERCC医疗中心接受治疗的患者中结核病的患病率。本次调查共纳入3029例结核病推定患者。总体结核病患病率为43.57%。男性993例(64.90%)，耐药率为10.1%;女性537例(35.09%)，耐药率为34.8%。所有年龄组的患病率最高，21-30岁年龄组共有350例(26.51%)，31-40岁年龄组共有327例(24.77%)。研究结果显示，有结核病药物治疗史和女性都与利福平耐药结核病的发展有关，年龄在21至40岁之间的患者比其他人更容易感染结核病并发展为利福平耐药结核病。由于流行率高，必须立即采取行动，鼓励早期发现和完成耐药结核病药物治疗，以防止该疾病在社区传播，并继续开展关于结核病和耐药性风险的社区卫生教育

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International Journal of Science Letters

自引率

0.00%

发文量